Exploring whether covid backlogs, coincidence or rare side effects are masking a genuine and significant signal
Professor emeritus Michel Goldman MD PhD is one of Europe’s leading doctors and immunologists. He’s the founder and the President of the I³h Institute and Professor of Immunology and Pharmacotherapy at the Université Libre de Bruxelles (ULB). He’s spent a lifetime developing new drugs and has been a long-running champion of vaccines, most recently mRNA vaccines used to combat covid-19 (C19).
When he wrote a piece for Science Business in February 2021 pushing for more C19 vaccines in Europe, he wouldn’t have known his own life might be compromised by the very products he was so passionately advocating.
Five months after receiving his second of two doses of the Pfizer C19 mRNA ‘genetic vaccine’, Prof Goldman felt unwell with flu-like symptoms and swollen lymph nodes. His brother, Serge Goldman, head of the nuclear medicine department at ULB, ran a CT scan of him. That led to the diagnosis of a specific type of lymphoma, AngioImmunoblastic T cell Lymphoma (AITL).